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Conclusions: Dose response for local control based on D90 of HR CTV 
is significant in a multicenter setting. Overall local control can be 
obtained in 95% of the patients when D90 of HR CTV>92 Gy. The 
analysis further points to FIGO stage, tumour width at diagnosis, 
volume of HR CTV and histology as important determinants for TCD90 
and TCD95.  
 
 POSTER DISCUSSION: 7: RTT  
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Purpose/Objective: To determine the current variation in 
radiotherapy practice for the treatment of cervical cancer across the 
United Kingdom (UK) with the aim of developing a comprehensive 
radiotherapy quality assurance (QA) programme for both external 
beam radiotherapy (EBRT) and brachytherapy within the context of 
the INTERLACE trial: a phase III trial of weekly induction 
chemotherapy and chemoradiation versus standard chemoradiation. 
The data will also be used to help determine the need for a national 
brachytherapy dosimetry audit. 
Materials and Methods: A pre-trial questionnaire was circulated to 31 
radiotherapy centres that had expressed interest in participating in 
INTERLACE. In addition to external beam radiotherapy (EBRT) details, 
in depth information on brachytherapy technique and QA was 
collected. 
Results: To date, 22 questionnaires have been completed and 
evaluated. Local practice was seen to vary significantly between 
centres with particular variation in brachytherapy techniques. For 
EBRT, all but 2 centres localise using CT and MRI modalities, only 6 of 
these also utilise PET imaging. Seven out of 22 centres use 3D virtual 
simulation (Vsim) techniques for EBRT planning. With respect to total 
EQD2 dose, 9 out of 22 centres did not achieve the proposed minimum 
dose requirement for the trial of 78 Gy, with values ranging from 68.3 
to 83.9 Gy. The intended trial requirement for the overall treatment 
time of ≤ 50 days was also not met by 7 of the 22 centres. Out of 21 
brachytherapy centres, 18 use 3D imaging for the planning of all 
fractions. Twelve of these optimise their plans for each individual 
patient; 6 to the target volume and 6 to OAR volumes or ICRU points, 
while the remaining 9 use standard plans. Six out of 21 centres have 
not participated in any brachytherapy dosimetry audit to date. 
Conclusions: The INTERLACE pre-trial questionnaire has revealed a 
wide variation in dose fractionation and treatment techniques being 
used in centres across the UK. Following our results new minimum 
standards for centres wishing to participate in the INTERLACE trial 
have been set. Now Vsim techniques for EBRT planning will not be 
permitted from UK centres. This will therefore require an advance in 
technique to 3D conformal planning for some centres. Several centres 
will be required to increase their total EQD2 dose for trial patients. 
The overall treatment time has now been amended to up to 56 days. 
Finally our results have highlighted the need for a national 
brachytherapy dosimetry audit which is now currently under 
development. 
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Background: Our instituition has been treating brain metastasis using 
LINAC based stereotactic radiosurgery with micromultileaf collimator 
(Brainlab M3) since 2008. Patients are immobilised using Brainlab 
fixation and treated with static fixed fields (6MV photon). In June 
2012 a TrueBeam STX (Varian Medical Systems) was installed. Patients 
with localised CNS lesions are now treated with 10MV flattening filter 
free (FFF) volumetric modulated arc therapy VMAT.  
Purpose: This study evaluated the impact of the new technique by 
comparing beam on time (BOT), time in room (TIR), and clinical dose 
rate (CDR) with the previous technique.  
Materials and Methods: BOT (minutes:seconds) is the aggregate 
‘‘beam-on’’ time for all fields or arcs in a given plan. TIR 
(minutes:seconds) is measured from the first alignment image to last 
beam off, inclusive of all pre-treatment imaging studies and/or shifts. 
Static field patients had MV imaging only. VMAT patients had kV 
imaging and pre-treatment cone beam CT (CBCT). Clinical dose rate 
(CDR) (MU/min) is the number of monitor units (MU) divided by the 
BOT. Treatment records were reviewed for 20 patients on Varian 
Eclipse and Offline review. The median planning target volume was 
5.41cm3 (min 0.98cm3 max 18.88cm3). 18 patients had single 
metastasis, 2 patients had 2 mets.10 patients were treated with 6MV 
static fields (between 4 and 6 fields) and 10 patients with 10MV FFF 
(All 10 Patients had 2 arcs). 11 patients were treated with 20Gy, 7: 
18Gy and 2: 15Gy.  
Results 
 6X STATIC VMAT 
BOT 5:85  
Range 4:55 – 6:6 
2:60 
Range 2:01 – 3.9 
TIR 34:17  
Range 20:42-58:13 
17:12  
Range 12:42 - 28:28
MU 2726 
Range 2119-3168 
MU 6216.5  
Range 4472-9340 
CDR 600 MU/min 2385.5 MU/min 
 
Conclusions: The implementation of VMAT FFF has dramatically 
reduced the TIR. The shorter BOT reduces the likelihood of 
intrafraction motion although this cannot be verified as no post 
treatment CBCT was performed. It is envisaged that VMAT FFF 
treatment times will be reduced further as Radiographer competency 
and skill increases. This is essential in busy RT departments where 
treatment slots are at a premium.  
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Purpose/Objective: This study examined the use of Systematic 
Common Terminology Criteria for Adverse Events v. 3.0 (CTC) 
registration to enable consistent patient care and prevention of acute 
side-effects from radiotherapy (RT). The goal was to enhance the 
ability of the radiation therapist nurses (RTN) to evaluate and act on 
acute side-effects. Hence we investigated whether performing CTC 
registration on specific weekdays compared to doing the registration 
on specific treatment fractions improved the quality of patient care as 
well as the toxicity data collection. Furthermore, we studied whether 
CTC registration combined with prior delegated medical actions and 
supplementary nurse prescribing reduced the need for physician 
consultations and interventions. 
Materials and Methods: We randomly selected 20 patients treated 
with RT for rectal cancer during October 2011. At that time point, 
CTC registration was done on every fifth day of the patient's 
treatment course. We evaluated the relative number of planned CTC 
registrations actually performed and all medical interventions. This 
was compared to similar data collected for 20 randomly selected 
rectal cancer patients treated during October 2012, where CTC 
